Active	Status	Sponsor type	Region	Phase	Filter
4 Active 3 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fasano, Alessio
NCT05636293: Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission	Recruiting	2	30	US	Ritlecitinib, Placebo, Gluten	Massachusetts General Hospital, Pfizer	Celiac Disease	08/25	08/25
CDGEMM, NCT02061306: Celiac Disease Genomic Environmental Microbiome and Metabolomic Study	Recruiting	N/A	500	Europe, US		Massachusetts General Hospital, University of Roma La Sapienza, Università Politecnica delle Marche	Celiac Disease	12/24	12/24
GEMMA, NCT04271774: Genome Environment Microbiome and Metabolome in Autism Study	Recruiting	N/A	600	Europe, US		Massachusetts General Hospital, Azienda Sanitaria Locale Salerno, National University of Ireland, Galway, Ireland	Autism Spectrum Disorder	12/25	12/25
Corrivetti, Giulio
GEMMA, NCT04271774: Genome Environment Microbiome and Metabolome in Autism Study	Recruiting	N/A	600	Europe, US		Massachusetts General Hospital, Azienda Sanitaria Locale Salerno, National University of Ireland, Galway, Ireland	Autism Spectrum Disorder	12/25	12/25